Select Cognition Coverage and Published Editorials
Armed With Donation From Trial Participant’s Family, Cognition (Nasdaq: CGTX) Initiates Expanded Access Program For Experimental DLB Drug
Benzinga
By Meg Flippin
June 11, 2025
Podcast: How are Biomarkers Shaping Alzheimer’s Disease, and What’s Next?
Touch Neurology
June 4, 2025
With Nicky Cartridge
Cognition Therapeutics Phase 2 Trials Of Zervimesine Show Promise In Treating Dry AMD, Alzheimer’s Disease And Dementia With Lewy Bodies
Benzinga
By Meg Flippin
May 22, 2025
Oral Zervimesine Slows Geographic Atrophy Progression in Phase 2 Dry AMD Trial
Ophthalmology Breaking News
May 14, 2025
Cognition Therapeutics Data Shows Retinal Cell Health Impact
Clinical Trial Vanguard
By Jon Napitupulu
May 12, 2025
Zervimesine Robustly Slows Geographic Atrophy Lesion Growth in Latest Phase 2 MAGNIFY Data
Neurology Live
By Marco Meglio
May 10, 2025
Connect with us on Social Media

